CGTX Cognition Therapeutics, Inc.

22h ago, source: Seeking Alpha

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and ...

Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2023 Earnings Call Transcript

1mon ago, source: Hosted on MSN

Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2023 Earnings Call Transcript March 26, 2024 Cognition Therapeutics, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the ...

Cognition to Host Virtual KOL in Mid-April

25d ago, source: Hosted on MSN

Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, today announced it will host a virtual KOL event on Friday ...

Cognition Therapeutics Stock (NASDAQ:CGTX), Analyst Ratings, Price Targets, Predictions

1mon ago, source: Benzinga.com

Cognition Therapeutics Inc has a consensus price target of $8, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from B. Riley Securities ...

Sage Therapeutics’ stock plunges as Parkinson’s drug trial disappoints

on MSN ago, source:

Sage Therapeutics shares dropped early Wednesday after the company said its experimental treatment for mild cognitive ...

Q4 2023 Cognition Therapeutics Inc Earnings Call

1mon ago, source: Yahoo Finance

Lisa Ricciardi; President, CEO; Cognition Therapeutics, Inc. John Doyle; CFO; Cognition Therapeutics, Inc. Tony Caggiano; Chief Medical Officer; Cognition ...

Cognition Therapeutics Inc (CGTX)

4d ago, source: Investing

PURCHASE, N.Y., March 14, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Cognition, the Company or We ) (Nasdaq: CGTX), a clinical stage company ...

Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2023 Earnings Call Transcript

1mon ago, source: Insider Monkey

Cognition Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, everyone, and welcome to Cognition ...

Cognition Therapeutics Inc CGTX

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Cognition Therapeutics Inc.

29d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...